Table 1. Correlation between PSMA3-AS1 and clinicopathological characteristics in 120 HEC patients.
| Variables | No. of patients | PSMA3-AS1 expression level | low | high | P | |||
| Age | 0.707 | |||||||
| <60 | 60 | 22 | 38 | |||||
| ≥60 | 60 | 24 | 36 | |||||
| Gender | 0.113 | |||||||
| Male | 70 | 31 | 39 | |||||
| Female | 50 | 15 | 35 | |||||
| Tumor stage | 0.000 | |||||||
| I–II | 55 | 32 | 23 | |||||
| III–IV | 65 | 14 | 51 | |||||
| Distant metastasis | 0.000 | |||||||
| Yes | 59 | 5 | 54 | |||||
| No | 61 | 41 | 20 | |||||
| Tumor size | 0.000 | |||||||
| ≤4 cm | 64 | 34 | 30 | |||||
| >4 cm | 56 | 12 | 44 | |||||
| Differentiation | 0.000 | |||||||
| Well/moderate | 60 | 34 | 26 | |||||
| Poor | 60 | 12 | 48 | |||||
*P values <0 .05 were considered statistically significant. The Pearson Chi- square test was used.